Global edition
Region
NewsWebcastsPodcastsCase StudiesThe Magazine
Sign inSubscribe
Follow Pharma Now@pharmanow.live
Editions & local coverage
United StatesUnited KingdomGermanyFranceItalyIndiaSwitzerlandSingapore

A global knowledge and leadership platform for pharma. We turn complexity into clarity professionals can act on.

Get the Pharma Now app

Read offline, save stories and never miss an edition.

Get it onGoogle PlayDownload on theApp Store
Verticals
  • Leadership
  • AI in Pharma
  • Manufacturing
  • Marketing
  • HR in Pharma
  • Microbiology & CCS
  • Regulatory Landscape
Formats
  • News & Analysis
  • Interviews
  • Case Studies
  • Webcasts
  • Podcasts
  • Events
  • Magazine
Knowledge Hub
  • Knowledge Hub
  • Research Papers
  • Buyer’s Guides
  • Companies
  • Newsletter Archive
  • Glossary
Company
  • Advisory Board
  • Contributors
  • Write for Us
  • Submit a PR
  • Contact
  • Advertise
Account
  • Subscribe
  • Sign in
  • My Account
  • Partner with us
Frequently asked

Pharma Now is a leading monthly B2B magazine focused on delivering in-depth content related to the pharmaceutical and biopharma sectors. It covers the latest trends, technological innovations, leadership insights, market developments, and interviews with industry experts.

Pharma Now provides comprehensive coverage, including: - Industry news and updates - Interviews with global pharma leaders - Market insights and trends - Innovations in AI, manufacturing, and pharma operations - Case studies, thought leadership articles, and regulatory updates

Pharma Now caters to a wide range of professionals within the pharmaceutical industry, including C-level executives, R&D professionals, quality managers, regulatory affairs specialists, and business leaders looking to stay informed about global trends and innovations.

You can subscribe to Pharma Now by visiting the Pharma Now website and choosing between print and digital editions.

Yes, Pharma Now welcomes contributions from industry experts. Contributors can submit articles, thought leadership pieces, and case studies. You can register on the contributors' page to submit content and gain recognition for your insights.

Pharma Now offers multiple advertising packages tailored to help companies promote their products, services, and innovations. From full-page ads to special event coverage, advertisers can reach a targeted audience of pharma professionals. For details, visit the Advertise With Us section on the website.

Copyright © 2026 Tantragyan Technologies Pvt Ltd. All Rights Reserved.
Privacy PolicyTerms of UseContact UsAdvertise
Knowledge Hub

Deep dives for pharma professionals

Research, innovation and market-trend explainers — the context behind the headlines, written for people who work in the industry.

54 articles in the hub
The Microbiome Revolution: Why Gut Microbes Are Shaping the Future of MedicineResearch

The Microbiome Revolution: Why Gut Microbes Are Shaping the Future of Medicine

See how gut microbes are reshaping drug discovery, precision medicine, and the future of healthcare.

Christian RoghiJun 26, 2026
Longevity at the Cellular Level: What Science Really SaysResearch

Longevity at the Cellular Level: What Science Really Says

Twelve hallmarks of aging, epigenetic clocks, senolytics and partial reprogramming, what's proven and what's still hype in 2026.

Mrudula KulkarniJun 20, 2026
Nutrition And Cell Signaling: Beyond Calories And MacrosResearch

Nutrition And Cell Signaling: Beyond Calories And Macros

Food activates mTOR, AMPK, NF-κB and Nrf2, the cell signaling pathways behind inflammation, aging and disease risk.

Simantini Singh DeoJun 19, 2026
Psychobiotics And Mental Health: Can Bacteria Influence Human Emotions?Research

Psychobiotics And Mental Health: Can Bacteria Influence Human Emotions?

Psychobiotics are live bacteria strains with proven effects on mood, anxiety, and cognition. Here's the gut-brain science pharma needs to know.

Simantini Singh DeoJun 16, 2026
Exercise as a Cellular Signal: How Movement Shapes BiologyResearch

Exercise as a Cellular Signal: How Movement Shapes Biology

Exercise is a message your cells understand. Explore how movement reshapes metabolism, resilience, and healthy aging.

Pritha MukherjeeJun 03, 2026
The Editing Revolution in Gene TherapyResearch

The Editing Revolution in Gene Therapy

Gene editing revolution | CRISPR/Cas9, base editing, prime editing, clinical applications & manufacturing challenges explained.

Heer ShahMay 19, 2026
GPT-Rosalind, Explained: What OpenAI's First Life Sciences Model Actually Changes for Pharma R&DResearch

GPT-Rosalind, Explained: What OpenAI's First Life Sciences Model Actually Changes for Pharma R&D

GPT-Rosalind explained OpenAI's first life sciences model, its benchmarks, gated access, and implications for global pharma R&D teams.

Ravindra WarangMay 06, 2026
How Anti-CD8 Alpha Antibody Helps in Determining Failure of a TreatmentResearch

How Anti-CD8 Alpha Antibody Helps in Determining Failure of a Treatment

Discover how anti-CD8 Alpha antibody helps researchers track T-cell response in immunotherapy and cancer diagnostics.

Team Pharma NowApr 14, 2026
Computer System Validator (CSV) vs. Computer System Assurance (CSA): What Are the Main Differences?Research

Computer System Validator (CSV) vs. Computer System Assurance (CSA): What Are the Main Differences?

Guide to Computer System Validation (CSV) vs Computer Software Assurance (CSA) in pharma with key differences and risk-based approach.

Vaibhavi M.Apr 10, 2026
PROTACs and Molecular Glues: How Targeted Protein Degradation Is Redefining Drug DiscoveryResearch

PROTACs and Molecular Glues: How Targeted Protein Degradation Is Redefining Drug Discovery

How PROTACs and molecular glues are redefining drug discovery through targeted protein degradation strategies.

Mrudula KulkarniFeb 13, 2026
Neuroinflammation As A Target Class: The New Frontier In CNS Drug DevelopmentResearch

Neuroinflammation As A Target Class: The New Frontier In CNS Drug Development

Why neuroinflammation is emerging as a major target class reshaping CNS drug development and neurology research.

Vaibhavi M.Feb 13, 2026
Senolytics and Microbiome Modifiers Two Quiet Levers Reshaping the Biology of AgeingResearch

Senolytics and Microbiome Modifiers Two Quiet Levers Reshaping the Biology of Ageing

How senolytics and microbiome modifiers are reshaping ageing biology by targeting inflammation, senescence, and system-level decline.

Mrudula KulkarniFeb 12, 2026
← Prev12…5Next →